The response to cardiovascular injury: A field of emerging complexity

• References

• 1 Schymeinsky J, Mócsai A, Walzog B. Neutrophil activation via β2 integrins (CD11/CD18): molecular mechanisms and clinical implications. Thromb Haemost 2007; 98: 262-273.
• 2 Hristov M, Zernecke A, Liehn EA. et al. Regulation of endothelial progenitor cell homing after arterial in jury. Thromb Haemost 2007; 98: 274-277.
• 3 Methe H, Hess S, Edelman ER. Endothelial immunogenicity – a matter of matrix microarchitecture. Thromb Haemost 2007; 98: 278-282.
• 4 Goerge T, Kleinerüschkamp F, Barg A. et al. Micro-fluidic reveals generation of platelet-strings on tumor-activated endothelium. Thromb Haemost 2007; 98: 283-286.
• 5 Fischer JW, Schrör K. Regulation of hyaluron synthesis by vasodilatory prostaglandins: implications for atherosclerosis. Thromb Haemost 2007; 98: 287-295.
• 6 Dimova EY, Jakubowska MM, Kietzmann T. CREB binding to the HIF-1 responsive elements in the plasminogen activator inhibitor-1 (PAI-1) promoter mediates the glucagon effect. Thromb Haemost 2007; 98: 296-303.
• 7 Liersch R, Detmar M. Lymphangiogenesis in development and disease. Thromb Haemost 2007; 98: 304-310.
• 8 Borchardt T, Braun T. Cardiovascular regeneration in non-mammalian model systems: what are the differences between newts and man?. Thromb Haemost 2007; 98: 311-318.